Compounds > triazoles
Page last updated: 2024-08-24

triazoles and Lipodystrophy

triazoles has been researched along with Lipodystrophy in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Assoumou, L; Chablais, L; Costagliola, D; Duvivier, C; Katlama, C; Kolta, S; Marcelin, AG; Mercié, P; Peytavin, G; Pialoux, G; Simon, A; Soulié, C; Valantin, MA1

Trials

1 trial(s) available for triazoles and Lipodystrophy

ArticleYear
Maraviroc plus raltegravir failed to maintain virological suppression in HIV-infected patients with lipohypertrophy: results from the ROCnRAL ANRS 157 study.
    The Journal of antimicrobial chemotherapy, 2014, Volume: 69, Issue:6

    Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Cyclohexanes; Female; HIV Infections; HIV-1; Humans; Lipodystrophy; Male; Maraviroc; Middle Aged; Pyrrolidinones; Raltegravir Potassium; Risk Factors; Treatment Failure; Triazoles; Viral Load

2014

Other Studies

1 other study(ies) available for triazoles and Lipodystrophy

ArticleYear
Anti-HIV agents. New drugs, new hope, old lessons.
    TreatmentUpdate, 2007, Volume: 19, Issue:2

    Topics: Alkynes; Anti-HIV Agents; Benzoxazines; CCR5 Receptor Antagonists; CD4 Lymphocyte Count; Cyclohexanes; Cyclopropanes; HIV Infections; HIV Integrase Inhibitors; Humans; Lipodystrophy; Maraviroc; Organic Chemicals; Pyrrolidinones; Raltegravir Potassium; Triazoles; Viral Load

2007